[对于类固醇依赖/耐药性慢性移植对宿主疾病的伊布鲁替尼的有效性和安全性:单中心分析]
Fumihiko Ouchi1, Yuho Najima1, Kana Kato1
1Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
在移植后的重症慢性移植对宿主疾病 (cGVHD) 中,易布鲁替尼 (IBR) 的疗效较小. 高感染率导致IBR治疗频繁停止,强调需要对感染进行警监测.
科学领域:
- 血液学
- 免疫学
- 癌症学
更多相关视频
08:17A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research
Published on: August 15, 2019
06:06Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR
Published on: May 23, 2019
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Ulcerative Colitis in IBD
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
